Literature DB >> 23532012

Risk factors for intracerebral hemorrhage: the REasons for geographic and racial differences in stroke (REGARDS) study.

George Howard1, Mary Cushman, Virginia J Howard, Brett M Kissela, Dawn O Kleindorfer, Claudia S Moy, Jeffery Switzer, Daniel Woo.   

Abstract

BACKGROUND AND
PURPOSE: Risk factors for intracerebral hemorrhage (ICH) have been largely identified in case-control studies, with few longitudinal studies available.
METHODS: Predictors of incident ICH among 27 760 black and white participants from the REasons for Geographic And Racial Differences in Stroke (REGARDS) cohort study were assessed.
RESULTS: There were 62 incident ICH events during an average follow-up of 5.7 years. The increase in risk with age differed substantially between blacks and whites (P=0.006), with a 2.25-fold (95% confidence interval, 1.63-3.12) increase per decade in whites, but no age association with ICH risk in blacks (hazard ratio=1.09; 95% confidence interval, 0.70-1.68). We observed increased risk among men, those with higher systolic blood pressure, and warfarin users.
CONCLUSIONS: The racial differences in the impact of age contributed to a risk of ICH that was >5 times higher for blacks than whites at age 45, but only about one third as great by age 85. Confirming findings from other studies, men participants with elevated systolic blood pressure and warfarin users were also at greater risk. The contributors to the racial differences in ICH risk require additional investigation.

Entities:  

Mesh:

Year:  2013        PMID: 23532012      PMCID: PMC3753577          DOI: 10.1161/STROKEAHA.111.000529

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  18 in total

1.  The reasons for geographic and racial differences in stroke study: objectives and design.

Authors:  Virginia J Howard; Mary Cushman; Leavonne Pulley; Camilo R Gomez; Rodney C Go; Ronald J Prineas; Andra Graham; Claudia S Moy; George Howard
Journal:  Neuroepidemiology       Date:  2005-06-29       Impact factor: 3.282

2.  Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge.

Authors:  W T Friedewald; R I Levy; D S Fredrickson
Journal:  Clin Chem       Date:  1972-06       Impact factor: 8.327

3.  Genetic and environmental risk factors for intracerebral hemorrhage: preliminary results of a population-based study.

Authors:  Daniel Woo; Laura R Sauerbeck; Brett M Kissela; Jane C Khoury; Jerzy P Szaflarski; James Gebel; Rakesh Shukla; Arthur M Pancioli; Edward C Jauch; Anil G Menon; Ranjan Deka; Janice A Carrozzella; Charles J Moomaw; Robert N Fontaine; Joseph P Broderick
Journal:  Stroke       Date:  2002-05       Impact factor: 7.914

4.  Oral anticoagulants vs aspirin in nonvalvular atrial fibrillation: an individual patient meta-analysis.

Authors:  Carl van Walraven; Robert G Hart; Daniel E Singer; Andreas Laupacis; Stuart Connolly; Palle Petersen; Peter J Koudstaal; Yuchiao Chang; Beppie Hellemons
Journal:  JAMA       Date:  2002-11-20       Impact factor: 56.272

5.  Serum cholesterol levels and six-year mortality from stroke in 350,977 men screened for the multiple risk factor intervention trial.

Authors:  H Iso; D R Jacobs; D Wentworth; J D Neaton; J D Cohen
Journal:  N Engl J Med       Date:  1989-04-06       Impact factor: 91.245

Review 6.  Risk factors for intracerebral hemorrhage in the general population: a systematic review.

Authors:  M J Ariesen; S P Claus; G J E Rinkel; A Algra
Journal:  Stroke       Date:  2003-07-03       Impact factor: 7.914

7.  The risk of subarachnoid and intracerebral hemorrhages in blacks as compared with whites.

Authors:  J P Broderick; T Brott; T Tomsick; G Huster; R Miller
Journal:  N Engl J Med       Date:  1992-03-12       Impact factor: 91.245

8.  Effect of untreated hypertension on hemorrhagic stroke.

Authors:  Daniel Woo; Mary Haverbusch; Padmini Sekar; Brett Kissela; Jane Khoury; Alexander Schneider; Dawn Kleindorfer; Jerzy Szaflarski; Arthur Pancioli; Edward Jauch; Charles Moomaw; Laura Sauerbeck; James Gebel; Joseph Broderick
Journal:  Stroke       Date:  2004-05-20       Impact factor: 7.914

Review 9.  Differential effects of lipid-lowering therapies on stroke prevention: a meta-analysis of randomized trials.

Authors:  Jean-Christophe Corvol; Anissa Bouzamondo; Marc Sirol; Jean-Sébastien Hulot; Paola Sanchez; Philippe Lechat
Journal:  Arch Intern Med       Date:  2003-03-24

Review 10.  Statin therapy and the risk of intracerebral hemorrhage: a meta-analysis of 31 randomized controlled trials.

Authors:  James S McKinney; William J Kostis
Journal:  Stroke       Date:  2012-05-15       Impact factor: 7.914

View more
  24 in total

1.  Black patients present with more severe vascular disease and a greater burden of risk factors than white patients at time of major vascular intervention.

Authors:  Peter A Soden; Sara L Zettervall; Sarah E Deery; Kakra Hughes; Michael C Stoner; Philip P Goodney; Ageliki G Vouyouka; Marc L Schermerhorn
Journal:  J Vasc Surg       Date:  2017-09-23       Impact factor: 4.268

Review 2.  Heart Disease and Stroke Statistics-2017 Update: A Report From the American Heart Association.

Authors:  Emelia J Benjamin; Michael J Blaha; Stephanie E Chiuve; Mary Cushman; Sandeep R Das; Rajat Deo; Sarah D de Ferranti; James Floyd; Myriam Fornage; Cathleen Gillespie; Carmen R Isasi; Monik C Jiménez; Lori Chaffin Jordan; Suzanne E Judd; Daniel Lackland; Judith H Lichtman; Lynda Lisabeth; Simin Liu; Chris T Longenecker; Rachel H Mackey; Kunihiro Matsushita; Dariush Mozaffarian; Michael E Mussolino; Khurram Nasir; Robert W Neumar; Latha Palaniappan; Dilip K Pandey; Ravi R Thiagarajan; Mathew J Reeves; Matthew Ritchey; Carlos J Rodriguez; Gregory A Roth; Wayne D Rosamond; Comilla Sasson; Amytis Towfighi; Connie W Tsao; Melanie B Turner; Salim S Virani; Jenifer H Voeks; Joshua Z Willey; John T Wilkins; Jason Hy Wu; Heather M Alger; Sally S Wong; Paul Muntner
Journal:  Circulation       Date:  2017-01-25       Impact factor: 29.690

3.  Untreated Hypertension: A Powerful Risk Factor for Lobar and Nonlobar Intracerebral Hemorrhage in Whites, Blacks, and Hispanics.

Authors:  Kyle B Walsh; Daniel Woo; Padmini Sekar; Jennifer Osborne; Charles J Moomaw; Carl D Langefeld; Opeolu Adeoye
Journal:  Circulation       Date:  2016-10-13       Impact factor: 29.690

4.  Haemostasis biomarkers and risk of intracerebral haemorrhage in the REasons for Geographic and Racial Differences in Stroke Study.

Authors:  Neil A Zakai; Nels C Olson; Suzanne E Judd; Dawn O Kleindorfer; Brett M Kissela; George Howard; Mary Cushman
Journal:  Thromb Haemost       Date:  2017-07-06       Impact factor: 5.249

5.  Race differences in platelet reactivity: is protease activated receptor 4 a predictor of response to therapy?

Authors:  Michele M Mumaw; Marvin T Nieman
Journal:  Arterioscler Thromb Vasc Biol       Date:  2014-12       Impact factor: 8.311

Review 6.  Neurologic Complications of Chronic Kidney Disease.

Authors:  Kavitha Vellanki; Vinod K Bansal
Journal:  Curr Neurol Neurosci Rep       Date:  2015-08       Impact factor: 5.081

7.  Racial differences in the association of insulin resistance with stroke risk: the REasons for Geographic And Racial Differences in Stroke (REGARDS) study.

Authors:  George Howard; Lynne E Wagenknecht; Walter N Kernan; Mary Cushman; Evan L Thacker; Suzanne E Judd; Virginia J Howard; Brett M Kissela
Journal:  Stroke       Date:  2014-06-26       Impact factor: 7.914

8.  Intracerebral haemorrhage: understanding racial differences in intracerebral haemorrhage.

Authors:  Ale Algra; Catharina J M Klijn
Journal:  Nat Rev Neurol       Date:  2013-06-04       Impact factor: 42.937

9.  Elevated rates of intracerebral hemorrhage in individuals from a US clinical care HIV cohort.

Authors:  Felicia C Chow; Wei He; Peter Bacchetti; Susan Regan; Steven K Feske; James B Meigs; Steven K Grinspoon; Virginia A Triant
Journal:  Neurology       Date:  2014-10-03       Impact factor: 9.910

10.  Challenge and Yield of Enrolling Racially and Ethnically Diverse Patient Populations in Low Event Rate Clinical Trials.

Authors:  Alice J Sheffet; George Howard; Albert Sam; Zafar Jamil; Fred Weaver; David Chiu; Jenifer H Voeks; Virginia J Howard; Susan E Hughes; Linda Flaxman; Mary E Longbottom; Thomas G Brott
Journal:  Stroke       Date:  2017-11-30       Impact factor: 7.914

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.